Trial · NCT02864914
Participant flow22
How many started, completed or left each group, period by period.
1 to 20 of 22
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Empagliflozin | 76,174 | |
| Overall Study | STARTED | DPP-4 Inhibitors | 257,406 | |
| Overall Study | Propensity Score-trimmed Cohort for DKA | Empagliflozin | 64,599 | |
| Overall Study | Propensity Score-trimmed Cohort for DKA | DPP-4 Inhibitors | 203,315 | |
| Overall Study | Propensity Score-trimmed Cohort for AKI | Empagliflozin | 58,393 | |
| Overall Study | Propensity Score-trimmed Cohort for AKI | DPP-4 Inhibitors | 167,823 | |
| Overall Study | Propensity Score-trimmed Cohort for ALI2 | Empagliflozin | 62,917 | |
| Overall Study | Propensity Score-trimmed Cohort for ALI2 | DPP-4 Inhibitors | 197,172 | |
| Overall Study | Propensity Score-trimmed Cohort for CKD - CPRD Only | Empagliflozin | 13,256 | |
| Overall Study | Propensity Score-trimmed Cohort for CKD - CPRD Only | DPP-4 Inhibitors | 62,435 | |
| Overall Study | Propensity Score-trimmed Cohort for GIM - CPRD Only | Empagliflozin | 8,272 | |
| Overall Study | Propensity Score-trimmed Cohort for GIM - CPRD Only | DPP-4 Inhibitors | 45,683 | |
| Overall Study | Propensity Score-trimmed Cohort for UTI - CPRD Only | Empagliflozin | 14,050 | |
| Overall Study | Propensity Score-trimmed Cohort for UTI - CPRD Only | DPP-4 Inhibitors | 77,330 | |
| Overall Study | Propensity Score-trimmed Cohort for GIF - CPRD Only | Empagliflozin | 5,802 | |
| Overall Study | Propensity Score-trimmed Cohort for GIF - CPRD Only | DPP-4 Inhibitors | 31,904 | |
| Overall Study | Propensity Score-trimmed Cohort for ALI1 | Empagliflozin | 36,053 | |
| Overall Study | Propensity Score-trimmed Cohort for ALI1 | DPP-4 Inhibitors | 154,554 | |
| Overall Study | COMPLETED | Empagliflozin | 76,174 | |
| Overall Study | COMPLETED | DPP-4 Inhibitors | 257,406 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02864914/flow